Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
Millar JS, et al. Among authors: diffenderfer mr.
J Lipid Res. 2008 Mar;49(3):543-9. doi: 10.1194/jlr.M700268-JLR200. Epub 2007 Nov 21.
J Lipid Res. 2008.
PMID: 18033754
Free article.
Clinical Trial.